Projects per year
Personal profile
Education
- 2004-2016 Ph.D., Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University
- 1999-2001 M.S., School of Medicine, Taipei Medical University
- 1987-1994 M.D., School of Medicine, Taipei Medical College
Experience
- 2025.02- Professor, Department of Pathology, School of Medicine, College of Medicin,e Taipei Medical University
- Attending, Department of Pathology, Taipei Municipal Wanfang Hospital
- Director, Department of Pathology, Taipei Municipal Wanfang Hospital
- 2022.08- Director, Department of Pathology, School of Medicine, College of Medicin,e Taipei Medical University
- 2019.08-2025.01 Associate Professor, Department of Pathology, School of Medicine, College of Medicin,e Taipei Medical University
- 2014.08-2019.07 Assistant Professor, Department of Pathology, School of Medicine, Taipei Medical University
- 2001.08-2014.07 Instructor, Department of Pathology, School of Medicine, Taipei Medical University
- 1996.09-2002.06 Resident Physician, Taipei Medical College Hospital
- 1996.07-1996.08 Resident Physician, Chang Gung Memorial Hospital
Research Interests
- Brain cancer, prostate cancer, cancer of gastrointestinal tract, immunohistochemistry, molecular pathology
Fingerprint
Dive into the research topics where Wei-Yu Chen is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 6 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Exploring the Mechanism and Clinical Significance of Egfr/Suclg2/Vegfa Driving the Neuroendocrine Differentiation of Prostate Cancer
Chen, W.-Y. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
Exploring the Mechanism and Clinical Significance of Egfr/Suclg2/Vegfa Driving the Neuroendocrine Differentiation of Prostate Cancer
Chen, W.-Y. (PI)
8/1/23 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
候選基因在子宮內膜異位、非癌性毛勒氏管組織，子宮內膜癌前病變和子宮內膜癌的表達(I/II)
Chen, W.-Y. (PI)
1/1/21 → 12/31/21
Project: B - Project of TMU › h - Higher Education Sprout Project
-
候選基因在子宮內膜異位、非癌性毛勒氏管組織，子宮內膜癌前病變和子宮內膜癌的表達(I/II)
Chen, W.-Y. (PI)
1/1/20 → 12/1/20
Project: B - Project of TMU › h - Higher Education Sprout Project
-
Targeting a Novel Neurotrophic Signaling Ngf-Chrm4 in Drug-Resistant Neuroendocrine Prostate Cancer
Chen, W.-Y. (PI)
8/1/19 → 7/31/20
Project: A - Government Institution › b - National Science and Technology Council
-
A calcium-sensing MCTP1/FYN/MEF2C circuit drives therapy-induced neuroendocrine prostate cancer
Dung, P. V. T., Chen, W. Y., Liu, M. K., Yeh, S. D., Kajla, G., Yeh, H. L., Chen, W. H., Jiang, K. C., Li, H. R., Chen, C. S., Beltran, H., Wen, Y. C. & Liu, Y. N., Jan 2026, In: Neoplasia (United States). 71, 101251.Research output: Contribution to journal › Article › peer-review
Open Access -
Programmable local immunochemotherapy for triple-negative breast cancer via spatiotemporally controlled release of CpG oligodeoxynucleotides, gemcitabine, and paclitaxel
Hsieh, C. H., Hsu, M. Y., Lin, C. F., Liu, C. C., Kuo, Y. H., Huang, Y. T., Chen, W. Y., Liu, S. J. & Lee, W. J., Dec 2026, In: npj Breast Cancer. 12, 1, 45.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus) -
Uremic toxin p‑cresyl sulfate enhances the calcification of aortic valvular interstitial cells via klotho/sirtuin‑1 signaling
Li, S. J., Cheng, T. Y., Kao, Y. H., Chen, W. Y., Chung, C. C., Trang, N. N., Chen, P. H. & Chen, Y. J., Jun 1 2026, In: Molecular Medicine Reports. 33, 6, 162.Research output: Contribution to journal › Article › peer-review
Open Access -
Widespread Yellowish to Brownish Plaques and Nodules
Shen, Y. H., Chen, W. Y. & Chiang, Y. Y., May 2026, In: Mayo Clinic Proceedings. 101, 5, p. 807-808 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Identification of mixed micro- and nanoparticle suspensions using an opto-microfluidic lab-on-a-chip system with Monte Carlo-based light extinction spectrometry
Dinh, Q. T., Chien, S. C., Chuang, H. Y., Chen, W. Y., Cheng, C. H., Chang, T. L., Chen, Y. B. & Liu, C. Y., Aug 16 2025, In: Sensors and Actuators A: Physical. 390, 116597.Research output: Contribution to journal › Article › peer-review
1 Link opens in a new tab Citation (Scopus)
Datasets
-
Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y.-C. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H.-L. (Contributor), Yin, J. J. (Creator), Lee, Y.-C. (Creator), Chen, W.-Y. (Creator) & Liu, Y.-N. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4008787.v1, https://doi.org/10.6084%2Fm9.figshare.c.4008787.v1
Dataset
-
Additional file 1: of Disruption of ETV6 leads to TWIST1-dependent progression and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in prostate cancer
Tsai, Y.-C. (Contributor), Zeng, T. (Creator), Abou-Kheir, W. (Creator), Yeh, H.-L. (Contributor), Yin, J. J. (Creator), Lee, Y.-C. (Creator), Chen, W.-Y. (Creator) & Liu, Y.-N. (Contributor), Figshare, 2018
DOI: 10.6084/m9.figshare.5900626.v1, https://springernature.figshare.com/articles/Additional_file_1_of_Disruption_of_ETV6_leads_to_TWIST1-dependent_progression_and_resistance_to_epidermal_growth_factor_receptor_tyrosine_kinase_inhibitors_in_prostate_cancer/5900626/1
Dataset